The Current Ratio as of December 2024 (TTM) for iSpecimen Inc. (ISPC) is 0.74

According to iSpecimen Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.74. This represents a change of -24.43% compared to the average of 0.98 of the last 4 quarters.

iSpecimen Inc. (ISPC) Historical Current Ratio (quarterly & annually)

How has ISPC Current Ratio performed in the past?

The mean historical Current Ratio of iSpecimen Inc. over the last ten years is 3.26. The current 0.74 Current Ratio has changed 2.18% with respect to the historical average. Over the past ten years (40 quarters), ISPC's Current Ratio was at its highest in in the March 2022 quarter at 14.73. The Current Ratio was at its lowest in in the September 2019 quarter at 0.

iSpecimen Inc. (ISPC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of iSpecimen Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

iSpecimen Inc. (ISPC) Average Current Ratio

How has ISPC Current Ratio performed in the past?

The current Current Ratio of iSpecimen Inc. (ISPC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

iSpecimen Inc. (ISPC) Current Ratio vs. Peers

How is ISPC’s Current Ratio compared to its peers?

iSpecimen Inc.’s Current Ratio is greater than Genetron Holdings Limited (0), less than Olink Holding AB (publ) (5.60), less than FONAR Corporation (9.64), less than Castle Biosciences, Inc. (7.78), less than Exagen Inc. (4.05), greater than OncoCyte Corporation (0.53), less than Personalis, Inc. (4.68), greater than Interpace Biosciences, Inc. (0.59), less than Trinity Biotech plc (1.64), greater than HTG Molecular Diagnostics, Inc. (0), less than Intelligent Bio Solutions Inc. (1.14), less than bioAffinity Technologies, Inc. (1.02), less than SeqLL Inc. (0.91), greater than T2 Biosystems, Inc. (0.40), less than Biocept, Inc. (2.97),

Build a custom stock screener for iSpecimen Inc. (ISPC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like iSpecimen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

iSpecimen Inc. (ISPC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like iSpecimen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.